Navigation Links
Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:5/9/2011

il Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.

Forward-Looking Statements

The Company cautions you that the statements included in this press release that are not a description of historical facts are forward-looking statements. These include statements regarding: the eventual commercial viability of the Company's drug programs; the eventual revenues that the Company would attain if the drug eventually gets approved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in the Company's business, including, without limitation: the results of any future clinical trials for iSONEP may not be favorable and the Company may never receive regulatory approval for iSONEP; and the Company may not be able to secure the funds necessary to support its clinical trial and product development plans. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q filed with the SEC. Such documents may be read free of charge on the SEC's web site at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.


'/>"/>

SOURCE Lpath, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Technest Holdings, Inc. to Acquire AccelPath, LLC; Issue Contingent Value Rights to Common Stockholders; and Issue Shares of Its Series E 5% Convertible Preferred Stock
2. Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
5. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
6. Threshold to Host Conference Call to Discuss Results From Clinical Presentations at European Cancer Conference (ECCO)
7. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
8. Spectrum Pharmaceuticals Announces Presentation of SPI-1620 Data at the AACR-NCI-EORTC International Conference
9. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
10. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
11. IDM Pharma Announces Upcoming Clinical Data Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)...  On August 5, 2015, the U.S. District Court ... denied motions to dismiss securities class action claims against ... of its directors. The class actions allege that the ... to artificially inflate Galena,s stock price, and during an ... inflated, sold massive amounts of their personally-held shares. ...
(Date:8/31/2015)... , Aug. 31, 2015  Dipexium Pharmaceuticals, Inc. ... on the development and commercialization of Locilex® (pexiganan cream ... announced plans to participate in four investor conferences in ... 2015 at the Sidoti & Company, LLC Emerging Growth ... . David P. Luci , President & Chief ...
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, 2015 ... SAN) and the life sciences team at Google announced ... outcomes for people with type 1 and type 2 ... devices with Google,s expertise in analytics, miniaturized electronics and ... to improve diabetes care by developing new tools that ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6
... PRINCETON, N.J., Sept. 24 DOR BioPharma, Inc. ... late-stage biotechnology company, announced today that it has entered into ... million. DOR,s North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated ... the terms of the agreements, DOR will sell approximately 15,200,000 ...
... Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced today ... the University of Texas Health Science Center ... 2 clinical trial using intravenous administration of REOLYSIN(R) in ... melanoma. The Principal Investigator is Dr. Devalingam Mahalingam, M.D., ...
Cached Medicine Technology:DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors 2DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors 3DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors 4Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial 2Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial 3Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial 4
(Date:8/31/2015)... ... August 31, 2015 , ... Dr. Paul Kovatis of Orthopedic Spine ... At OSSMC, Dr. Kovatis treats all surgical and non-surgical disorders of the leg, ankle ... entire musculoskeletal system, excluding the spine. , Dr. Paul Kovatis completed his orthopedic leg, ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can healthcare ... hold down costs? , In a commentary for The American Journal of ... concept of “clinical efficacy,” which would bind parties together in agreements to intervene ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... at the 16th Innovations in Healthcare(SM) Awards Event , on October 21, ... (ABL) Organization , recognizes innovative organizations and individuals who are dramatically reducing the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, ... ribbon-cutting ceremony on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, ... AdvantaClean’s National Call Center and website since Aug. 17. , The Greens have ...
(Date:8/31/2015)... ... August 31, 2015 , ... DR. LUCIANA ON ... (aka Dr. Luciana) received a total of three Silver Medal awards at ... Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this pilot with Del Weston, ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2
... , TUESDAY, Sept. 27 (HealthDay News) -- Rude employee ... from many businesses, a new U.S. study finds. ... said they,d experienced or witnessed insensitive, disrespectful or rude ... consumers said this incivility makes them less likely to ...
... rates linked to climate change will increase in several European ... study, which will be presented today (27 September 2011) at ... Belgium, France, Spain and Portugal will see the biggest climate-induced ... The research is part of the Climate-TRAP project and ...
... birth can have on the lungs of babies could be ... prematurely but may be reversed in their teenage years, according ... at the European Respiratory Society Annual Congress in Amsterdam today ... allows enough time for the infant to fully grow and ...
... Reporter , MONDAY, Sept. 26 (HealthDay News) -- U.S. health ... of blood clots in women taking newer forms of birth ... short of a definitive statement, the U.S. Food and Drug ... higher risk of blood clots in women taking the "fourth ...
... an ongoing debate: Should men over a certain age be ... treatments that may result in significant side effects if they ... by researchers at UCLA,s Jonsson Comprehensive Cancer Center has shown ... while patients with a single comorbid condition such as peripheral ...
... News) -- People with heart disease who undergo cardiac rehabilitation ... rate after exercise, a new study suggests. Researchers at ... recovery live longer than those whose hearts remain revved up ... that can do that," study author Dr. Leslie Cho, director ...
Cached Medicine News:Health News:Climate change set to increase ozone-related deaths over next 60 years 2Health News:Lung function of moderately premature babies is reduced at 8-9 years but may improve with age 2Health News:Newer Contraceptive Pills Could Raise Clot Risk, FDA Warns 2Health News:Elderly patients may be undertreated for prostate cancer 2Health News:Elderly patients may be undertreated for prostate cancer 3Health News:Cardiac Rehab May Help Heart Patients Live Longer 2
... first time, the Integrated Cytometry Solution ... post-analytical solution coupled with complete LIS ... steps a sample undergoes - and ... one - it delivers a progressive ...
Convective Air Warming Blankets...
MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...
Inquire...
Medicine Products: